- World rank, all time
- #30,974 of 42,892
- Rank in Ireland
- #104 of 152
- Research works
- 160 ▲ 30% vs 2013–17
- Citations
- 5k 31.4 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 39% world 28%
What does Cancer Trials Ireland specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.7× the share of its output that it takes of world research.
- MedicineField · 31.4 works3.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.7×. Every wedge is a field page.
- Medicine 3.7×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Health Professions 1.8×
- Economics, Econometrics and Finance 1.6×
- Immunology and Microbiology 1.5×
- Physics and Astronomy 1.0×
- Neuroscience 0.6×
- Environmental Science 0.3×
- Chemistry 0.3×
- Nursing 0.3×
- Mathematics 0.2×
- Decision Sciences 0.2×
- Social Sciences 0.1×
- Engineering 0.0×
Who are the top researchers at Cancer Trials Ireland?
Ranked on the composite score, John G. Armstrong and David Fitzpatrick lead among researchers whose main affiliation is Cancer Trials Ireland.
- 1 John G. Armstrong Ireland · #940,217 worldwide 24 citations · 15 works
- 2 David Fitzpatrick Ireland · #1,354,522 worldwide 0 citations · 17 works
Which keywords describe research at Cancer Trials Ireland?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Clinical Trials, Breast Cancer, Biomarkers, Clinical Guidelines, Prostate Cancer and Cancer.
- Dosimetry
- Patient Outcomes
- Health-related Quality of Life
- MRI Imaging
- Gene Expression
- Precision Medicine
- Tumor Microenvironment
- Genetic Mutations
- Hormone Therapy
- Lung Cancer
- Health Economics
- Genomic Profiling
- Radiation Therapy
- Immunotherapy
- Medical Education
- Cancer Treatment
- Prostate Cancer
- Cancer
- Breast Cancer
- Radiotherapy
- Chemotherapy
- Clinical Trials
- Biomarkers
- Clinical Guidelines
- Quality of Life
- Clinical Practice Guidelines
- Adjuvant Therapy
- Mortality
- Screening
- Global Access
- CT Screening
- Survival Analysis
- Targeted Therapy
- Ovarian Cancer
- Genetic Variants
- Biopsy
- Gleason Grading
- Metastasis
- Neoadjuvant Therapy
- Quality Assessment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy6▲ 21×19 topics
- Radiotherapy6▲ 36×9 topics
- Clinical Trials4▲ 14×9 topics
- Breast Cancer3▲ 32×9 topics
- Biomarkers3▲ 10×11 topics
- Cancer3▲ 5.2×18 topics
- Clinical Guidelines3▲ 22×3 topics
- Prostate Cancer3▲ 46×4 topics
- Quality of Life3▲ 4.2×7 topics
- Cancer Treatment2▲ 23×3 topics
- Clinical Practice Guidelines2▲ 10×8 topics
- Medical Education2▲ 21×3 topics
- Adjuvant Therapy2▲ 40×2 topics
- Immunotherapy2▲ 7.1×11 topics
- Mortality2▲ 8.5×4 topics
- Radiation Therapy2▲ 38×2 topics
- Screening2▲ 52×2 topics
- Genomic Profiling2▲ 45×2 topics
- Global Access2▲ 53×1 topic
- Health Economics2▲ 94×1 topic
- CT Screening2▲ 66×1 topic
- Lung Cancer2▲ 26×1 topic
- Survival Analysis2▲ 16×5 topics
- Hormone Therapy2▲ 51×3 topics
- Targeted Therapy2▲ 18×5 topics
- Genetic Mutations2▲ 8.8×6 topics
- Ovarian Cancer2▲ 43×3 topics
- Tumor Microenvironment2▲ 8.5×6 topics
- Genetic Variants2▲ 21×4 topics
- Precision Medicine2▲ 7.8×4 topics
- Biopsy2▲ 57×2 topics
- Gene Expression2▲ 5.6×5 topics
- Gleason Grading2▲ 84×1 topic
- MRI Imaging2▲ 40×1 topic
- Metastasis2▲ 10×8 topics
- Health-related Quality of Life1▲ 14×3 topics
- Neoadjuvant Therapy1▲ 14×5 topics
- Patient Outcomes1▲ 52×2 topics
- Quality Assessment1▲ 17×2 topics
- Dosimetry1▲ 43×2 topics
Which research topics does Cancer Trials Ireland publish most on?
By volume in 2022–2025: Advances in Oncology and Radiotherapy, Lung Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment and Clinical practice guidelines implementation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 2 works
- 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 3 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 4 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 1 works
- 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 6 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 7 Cancer survivorship and care Oncology 1 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 9 Advanced Radiotherapy Techniques Radiation 1 works
- 10 HER2/EGFR in Cancer Research Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cancer Trials Ireland's research output changed?
Output in 2018–2022 was 30% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dublin
- University College Dublin
- Trinity College Dublin
- Dublin City University
- Royal College of Surgeons in Ireland
- St. James's Hospital
- St. Vincent's University Hospital
- Technological University Dublin
- National University of Ireland
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.